These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 27208380)

  • 21. Role of Serum Adiponectin and Vitamin D in Prediabetes and Diabetes Mellitus.
    Banerjee A; Khemka VK; Roy D; Poddar J; Roy TKS; Karnam SA
    Can J Diabetes; 2017 Jun; 41(3):259-265. PubMed ID: 28236525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts.
    Floegel A; Kühn T; Sookthai D; Johnson T; Prehn C; Rolle-Kampczyk U; Otto W; Weikert C; Illig T; von Bergen M; Adamski J; Boeing H; Kaaks R; Pischon T
    Eur J Epidemiol; 2018 Jan; 33(1):55-66. PubMed ID: 29181692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics in diabetes, a review.
    Pallares-Méndez R; Aguilar-Salinas CA; Cruz-Bautista I; Del Bosque-Plata L
    Ann Med; 2016; 48(1-2):89-102. PubMed ID: 26883715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis.
    Glechner A; Keuchel L; Affengruber L; Titscher V; Sommer I; Matyas N; Wagner G; Kien C; Klerings I; Gartlehner G
    Prim Care Diabetes; 2018 Oct; 12(5):393-408. PubMed ID: 30076075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study.
    Ligthart S; van Herpt TT; Leening MJ; Kavousi M; Hofman A; Stricker BH; van Hoek M; Sijbrands EJ; Franco OH; Dehghan A
    Lancet Diabetes Endocrinol; 2016 Jan; 4(1):44-51. PubMed ID: 26575606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose.
    Merino J; Leong A; Liu CT; Porneala B; Walford GA; von Grotthuss M; Wang TJ; Flannick J; Dupuis J; Levy D; Gerszten RE; Florez JC; Meigs JB
    Diabetologia; 2018 Jun; 61(6):1315-1324. PubMed ID: 29626220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic signature shift in type 2 diabetes mellitus revealed by mass spectrometry-based metabolomics.
    Xu F; Tavintharan S; Sum CF; Woon K; Lim SC; Ong CN
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1060-5. PubMed ID: 23633210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort.
    Shi L; Brunius C; Lehtonen M; Auriola S; Bergdahl IA; Rolandsson O; Hanhineva K; Landberg R
    Diabetologia; 2018 Apr; 61(4):849-861. PubMed ID: 29349498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma amino acid and metabolite signatures tracking diabetes progression in the UCD-T2DM rat model.
    Piccolo BD; Graham JL; Stanhope KL; Fiehn O; Havel PJ; Adams SH
    Am J Physiol Endocrinol Metab; 2016 Jun; 310(11):E958-69. PubMed ID: 27094034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomic Profile of Skeletal Muscle and Its Change Under a Mixed-Mode Exercise Intervention in Progressively Dysglycemic Subjects.
    Szczerbinski L; Golonko A; Taylor M; Puchta U; Konopka P; Paszko A; Citko A; Szczerbinski K; Gorska M; Zabielski P; Błachnio-Zabielska A; Larsen S; Kretowski A
    Front Endocrinol (Lausanne); 2021; 12():778442. PubMed ID: 34938272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes and diabetes mellitus.
    Mertoglu C; Gunay M
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S127-S131. PubMed ID: 28017281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early Metabolic Features of Genetic Liability to Type 2 Diabetes: Cohort Study With Repeated Metabolomics Across Early Life.
    Bell JA; Bull CJ; Gunter MJ; Carslake D; Mahajan A; Davey Smith G; Timpson NJ; Vincent EE
    Diabetes Care; 2020 Jul; 43(7):1537-1545. PubMed ID: 32345654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of amino acids and acylcarnitines combined with untargeted metabolomics using ultra-high performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
    Roy C; Tremblay PY; Bienvenu JF; Ayotte P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1027():40-9. PubMed ID: 27240302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolite changes in risk of type 2 diabetes mellitus in cohort studies: A systematic review and meta-analysis.
    Park JE; Lim HR; Kim JW; Shin KH
    Diabetes Res Clin Pract; 2018 Jun; 140():216-227. PubMed ID: 29626587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase-8 analysis in patients with periodontal disease with prediabetes or type 2 diabetes mellitus: A systematic review.
    de Morais EF; Dantas AN; Pinheiro JC; Leite RB; Galvao Barboza CA; de Vasconcelos Gurgel BC; de Almeida Freitas R
    Arch Oral Biol; 2018 Mar; 87():43-51. PubMed ID: 29248700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolites in peripheral blood mononuclear cells showed greater differences between patients with impaired fasting glucose or type 2 diabetes and healthy controls than those in plasma.
    Kim M; Kim M; Han JY; Lee SH; Jee SH; Lee JH
    Diab Vasc Dis Res; 2017 Mar; 14(2):130-138. PubMed ID: 28185532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of metabolite profiles as biomarkers for the pharmacological effects of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers.
    van Doorn M; Vogels J; Tas A; van Hoogdalem EJ; Burggraaf J; Cohen A; van der Greef J
    Br J Clin Pharmacol; 2007 May; 63(5):562-74. PubMed ID: 17488363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach.
    Floegel A; Stefan N; Yu Z; Mühlenbruch K; Drogan D; Joost HG; Fritsche A; Häring HU; Hrabě de Angelis M; Peters A; Roden M; Prehn C; Wang-Sattler R; Illig T; Schulze MB; Adamski J; Boeing H; Pischon T
    Diabetes; 2013 Feb; 62(2):639-48. PubMed ID: 23043162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht Study.
    Biggelaar LJ; Eussen SJ; Sep SJ; Mari A; Ferrannini E; Dongen MC; Denissen KF; Wijckmans NE; Schram MT; Kallen CJ; Koster A; Schaper N; Henry RM; Stehouwer CD; Dagnelie PC
    Nutrients; 2017 Apr; 9(4):. PubMed ID: 28406435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.